Tyra Biosciences Stock Investor Sentiment

TYRA Stock  USD 10.88  0.14  1.30%   
About 52% of Tyra Biosciences' investor base is interested to short. The analysis of the overall investor sentiment regarding Tyra Biosciences suggests that many traders are impartial. The current market sentiment, together with Tyra Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Tyra Biosciences stock news signals to limit their universe of possible portfolio assets.
  

Tyra Biosciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Tyra Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
2 days ago at news.google.com         
Why Precision BioSciences Shares Are Trading Higher By Over 10 Here Are 20 Stocks Moving Premarket -...
Google News at Macroaxis
few days ago at thelincolnianonline.com         
Acquisition by Alan Fuhrman of 1238 shares of Tyra Biosciences at 9.775 subject to Rule 16b-3
news
few days ago at www.macroaxis.com         
Disposition of 4900 shares by Todd Harris of Tyra Biosciences at 25.2155 subject to Rule 16b-3
Macroaxis News
over a week ago at news.google.com         
Rhumbline Advisers Grows Stake in Tyra Biosciences, Inc. - Defense World
Google News at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of 1890 shares by Kjellson Nina S of Tyra Biosciences at 13.7611 subject to Rule 16b-3
Macroaxis News
over two weeks ago at news.google.com         
Tyra Biosciences, Inc. Sees Large Growth in Short Interest - Defense World
Google News at Macroaxis
over two weeks ago at www.macroaxis.com         
Disposition of 73093 shares by Daniel Bensen of Tyra Biosciences at 16.3066 subject to Rule 16b-3
Macroaxis News
over two weeks ago at news.google.com         
Investment Report - Stock Traders Daily
Google News at Macroaxis
over two weeks ago at news.google.com         
Tyra Biosciences FGFR12 Driven AE Data Spooked The Market - Seeking Alpha
Google News at Macroaxis
over two weeks ago at finance.yahoo.com         
BlueNord Update on Tyra Redevelopment Project and Tyra Completion Test
Yahoo News
over two weeks ago at news.google.com         
Tyra Biosciences stock hits 52-week low at 11.88 amid market shifts - Investing.com India
Google News at Macroaxis
over three weeks ago at news.google.com         
Investment Analysis - Stock Traders Daily
Google News at Macroaxis
over three weeks ago at news.google.com         
Tyra Biosciences Stock Price Up 6.6 percent - Heres What Happened - MarketBeat
Google News at Macroaxis
over a month ago at gurufocus.com         
BIOTECHNOLOGY VALUE FUND L P Reduces Stake in Tyra Biosciences Inc
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
Tyra Biosciences Hits New 52-Week Low Heres Why
news
Far too much social signal, news, headlines, and media speculation about Tyra Biosciences that are available to investors today. That information is available publicly through Tyra media outlets and privately through word of mouth or via Tyra internal channels. However, regardless of the origin, that massive amount of Tyra data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Tyra Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tyra Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tyra Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tyra Biosciences alpha.

Tyra Biosciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of tradable shares by Moran Susan of Tyra Biosciences subject to Rule 16b-3
12/17/2024
2
Disposition of 835 shares by Kjellson Nina S of Tyra Biosciences at 16.287 subject to Rule 16b-3
01/16/2025
3
Disposition of 93 shares by Kjellson Nina S of Tyra Biosciences at 16.3626 subject to Rule 16b-3
01/21/2025
4
Tyra Biosciences, Inc. Director Nina S. Kjellson Sells 7,779 Shares
01/22/2025
5
Disposition of 4825 shares by Kjellson Nina S of Tyra Biosciences at 16.2624 subject to Rule 16b-3
01/23/2025
6
Insider Selling Tyra Biosciences, Inc. Director Sells 4,825 Shares of Stock - MarketBeat
01/27/2025
7
Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors
01/29/2025
8
Disposition of 3511 shares by Kjellson Nina S of Tyra Biosciences at 13.7611 subject to Rule 16b-3
02/05/2025
9
Tyra Biosciences to Present at Upcoming Investor Conferences - Quantisnow
02/11/2025
10
Tyra Biosciences Stock Price Up 6.6 percent - Heres What Happened - MarketBeat
02/18/2025
11
BlueNord Update on Tyra Redevelopment Project and Tyra Completion Test
02/28/2025
12
Disposition of 73093 shares by Daniel Bensen of Tyra Biosciences at 16.3066 subject to Rule 16b-3
03/03/2025
13
Disposition of 1890 shares by Kjellson Nina S of Tyra Biosciences at 13.7611 subject to Rule 16b-3
03/07/2025
14
Rhumbline Advisers Grows Stake in Tyra Biosciences, Inc. - Defense World
03/10/2025
15
Disposition of 4900 shares by Todd Harris of Tyra Biosciences at 25.2155 subject to Rule 16b-3
03/13/2025
16
Why Precision BioSciences Shares Are Trading Higher By Over 10 Here Are 20 Stocks Moving Premarket - Benzinga
03/17/2025

Complementary Tools for Tyra Stock analysis

When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance